Total Payments
$1,860
2024 Payments
$188.48
Companies
17
Transactions
35
Medicare Patients
539
Medicare Billing
$68,328
Payment Breakdown by Category
Food & Beverage$1,860 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,860 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $434.18 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $242.20 | 2 | $0 (2024) |
| EUSA Pharma (US) LLC | $230.94 | 2 | $0 (2021) |
| PFIZER INC. | $141.99 | 10 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $141.84 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $114.59 | 1 | $0 (2021) |
| Amgen Inc. | $106.84 | 1 | $0 (2021) |
| Incyte Corporation | $98.71 | 1 | $0 (2023) |
| Kite Pharma, Inc. | $88.97 | 1 | $0 (2022) |
| Seagen Inc. | $86.83 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $188.48 | 2 | AstraZeneca Pharmaceuticals LP ($118.88) |
| 2023 | $386.46 | 5 | AstraZeneca Pharmaceuticals LP ($123.32) |
| 2022 | $88.97 | 1 | Kite Pharma, Inc. ($88.97) |
| 2021 | $950.44 | 10 | GENZYME CORPORATION ($367.32) |
| 2020 | $44.37 | 3 | PFIZER INC. ($44.37) |
| 2019 | $45.24 | 3 | Novartis Pharmaceuticals Corporation ($33.04) |
| 2018 | $56.00 | 4 | PFIZER INC. ($39.62) |
| 2017 | $99.97 | 7 | E.R. Squibb & Sons, L.L.C. ($33.70) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $118.88 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Janssen Scientific Affairs, LLC | DARZALEX (Drug) | Food and Beverage | In-kind items and services | $69.60 | General |
| Category: Oncology | ||||||
| 12/11/2023 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), TALVEY, IMBRUVICA | Food and Beverage | In-kind items and services | $72.24 | General |
| Category: Oncology | ||||||
| 11/02/2023 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $66.86 | General |
| Category: Hematology | ||||||
| 08/24/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $123.32 | General |
| Category: Oncology | ||||||
| 05/23/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $98.71 | General |
| Category: Hematology/Oncology | ||||||
| 12/12/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $88.97 | General |
| 12/07/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $86.83 | General |
| Category: Oncology | ||||||
| 11/03/2021 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Oncology | ||||||
| 10/28/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $119.21 | General |
| Category: Oncology | ||||||
| 09/30/2021 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $114.59 | General |
| 09/23/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $106.84 | General |
| Category: Oncology | ||||||
| 08/26/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 08/04/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/03/2021 | EUSA Pharma (US) LLC | Sylvant (Drug) | Food and Beverage | In-kind items and services | $115.47 | General |
| Category: Hematology | ||||||
| 08/03/2021 | EUSA Pharma (US) LLC | Sylvant (Drug) | Food and Beverage | In-kind items and services | $115.47 | General |
| Category: Hematology | ||||||
| 07/01/2021 | Secura Bio, Inc. | FARYDAK (Drug), COPIKTRA | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 02/25/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/31/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/28/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 145 | 283 | $40,240 | $21,448 |
| 2020 | 5 | 394 | 663 | $88,980 | $46,880 |
Total Patients
539
Total Services
946
Medicare Billing
$68,328
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 121 | $18,150 | $9,683 | 53.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 46 | 111 | $11,655 | $6,145 | 52.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 23 | $6,095 | $3,389 | 55.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 27 | 28 | $4,340 | $2,231 | 51.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 155 | 381 | $40,005 | $20,642 | 51.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 103 | 105 | $16,275 | $8,592 | 52.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 58 | 58 | $15,370 | $8,555 | 55.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 65 | 106 | $15,900 | $8,362 | 52.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 13 | $1,430 | $729.08 | 51.0% |
About Dr. Arash Velayati, M.D
Dr. Arash Velayati, M.D is a Hematology & Oncology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689093692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arash Velayati, M.D has received a total of $1,860 in payments from pharmaceutical and medical device companies, with $188.48 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,860).
As a Medicare-enrolled provider, Velayati has provided services to 539 Medicare beneficiaries, totaling 946 services with total Medicare billing of $68,328. Data is available for 2 years (2020–2021), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Sacramento, CA
- Active Since 04/08/2014
- Last Updated 08/14/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1689093692
Products in Payments
- LIBTAYO (Biological) $244.20
- Sylvant (Drug) $230.94
- TAGRISSO (Drug) $123.32
- JEVTANA (Drug) $123.12
- CALQUENCE (Drug) $118.88
- Kyprolis (Drug) $106.84
- JAKAFI (Drug) $98.71
- ELIQUIS (Drug) $98.17
- ADCETRIS (Biological) $86.83
- CHANTIX (Drug) $77.52
- TECVAYLI (Biological) $72.24
- DARZALEX (Drug) $69.60
- CABLIVI (Biological) $66.86
- ENTRESTO (Drug) $33.04
- SAMSCA (Drug) $26.69
- VENCLEXTA (Drug) $25.33
- FARYDAK (Drug) $23.82
- XARELTO (Drug) $16.38
- ORBACTIV (Drug) $13.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Sacramento
Dr. Joseph Tuscano, M.d, M.D
Hematology & Oncology — Payments: $633,262
Hematology & Oncology $633,262
Adam Giermasz, M.d., Phd, M.D., PHD
Hematology & Oncology — Payments: $518,605
Hematology & Oncology $518,605
Dr. David Gandara, M.d, M.D
Hematology & Oncology — Payments: $462,968
Hematology & Oncology $462,968
Dr. Scott Christensen, M.d, M.D
Hematology & Oncology — Payments: $391,606
Hematology & Oncology $391,606
Karen Kelly, M.d, M.D
Hematology & Oncology — Payments: $306,992
Hematology & Oncology $306,992
Paul Kaesberg, M.d, M.D
Hematology & Oncology — Payments: $221,939
Hematology & Oncology $221,939